glutathione and isotretinoin UPSHER-SMITH LAUNCHES CAPSULES, USP Glutathione Capsules and Isotretinoin: Safe
Description
Any unexpected symptom that develops after initiating the combined protocol should be evaluated in the context of potential compound interactions
For the 4 mg dose, there was no significant difference compared to the placebo group, with an RR of 1.11 (95% CI: 0.93 to 1.31, P = 0.24)
Recognizing the signs, from persistent fatigue and brain fog to mood changes and tingling, is the first step, and a simple blood test can confirm whether B12 is the cause
& Matsuda, H
